期刊文献+

非酒精性脂肪性肝病的治疗进展 被引量:6

The therapeutic progress of non-alcoholic fatty liver disease
在线阅读 下载PDF
导出
摘要 非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)的治疗主要分为基础治疗、药物治疗和外科手术治疗。其中,基础治疗主要是通过行为、饮食和运动治疗来缓解NAFLD的发生和发展,药物治疗多是针对疾病不同病理环节而选取相应的药物,主要包括改善胰岛素抵抗(insulin resistance,IR)、对抗脂质过氧化损伤、保护肝细胞及纠正血脂紊乱等,外科手术治疗包括减肥手术和肝移植手术。本文对NAFLD治疗的相关进展作一概述。 The treatments of non-alcoholic fatty liver disease( NAFLD) mainly include basic treatment,drug therapy and surgical treatment. The basic treatment is mainly through behavior,diet and exercise therapy to alleviate the occurrence and development of NAFLD. Drug therapy is mainly aimed at selecting the appropriate drugs to different pathological aspects of the disease,and the drugs mainly include: improving insulin resistance( IR) drugs,antagonizing lipid peroxidation damage drugs,protecting liver cells drugs and rectifying blood lipid disorders drugs. Surgical treatments mainly involve bariatric surgery and liver transplantation. This article summarized the progress of NAFLD therapy to offer new options for the prevention and treatment of the disease.
机构地区 解放军第
出处 《胃肠病学和肝病学杂志》 CAS 2017年第10期1091-1093,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 非酒精性脂肪性肝病 治疗 进展 Non-alcoholic fatty liver disease Therapy Progress
  • 相关文献

参考文献3

二级参考文献17

  • 1Wu, Sheng-Di,Wang, Ji-Yao,Li, Lei.Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model:A comparative study[J].World Journal of Gastroenterology,2010,16(4):501-507. 被引量:26
  • 2Sombat Treeprasertsuk,Einar Bjrnsson,Felicity Enders,Sompongse Suwanwalaikorn,Keith D Lindor.NAFLD fibrosis score:A prognostic predictor for mortality and liver complications among NAFLD patients[J].World Journal of Gastroenterology,2013,19(8):1219-1229. 被引量:13
  • 3Maitreyi Raman,Iftikhar Ahmed,Patrick M. Gillevet,Chris S. Probert,Norman M. Ratcliffe,Steve Smith,Rosemary Greenwood,Masoumeh Sikaroodi,Victor Lam,Pam Crotty,Jennifer Bailey,Robert P. Myers,Kevin P. Rioux.Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease[J].Clinical Gastroenterology and Hepatology.2013(7)
  • 4Edith M. Koehler,Jeoffrey N.L. Schouten,Bettina E. Hansen,Albert Hofman,Bruno H. Stricker,Harry L.A. Janssen.External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study[J].Clinical Gastroenterology and Hepatology.2013
  • 5D. Festi,R. Schiumerini,L. Marzi,A. R. Di Biase,D. Mandolesi,L. Montrone,E. Scaioli,G. Bonato,G. Marchesini‐Reggiani,A. Colecchia.Review article: the diagnosis of non‐alcoholic fatty liver disease – availability and accuracy of non‐invasive methods[J].Aliment Pharmacol Ther.2012(4)
  • 6Victor de Lédinghen,Vincent Wai-Sun Wong,Julien Vergniol,Grace Lai-Hung Wong,Juliette Foucher,Shirley Ho-Ting Chu,Brigitte Le Bail,Paul Cheung-Lung Choi,Faiza Chermak,Karen Kar-Lum Yiu,Wassil Merrouche,Henry Lik-Yuen Chan.Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan?[J].Journal of Hepatology.2011(4)
  • 7MaitreyiRaman,Raylene A.Reimer.The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistance[J].Liver Int.2012(5)
  • 8Erin Marie McCarthy,Mary E. Rinella.The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease[J].Journal of the American Dietetic Association.2012(3)
  • 9Hemant Chatrath,Raj Vuppalanchi,Naga Chalasani.Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease[J].Semin Liver Dis.2012(01)
  • 10Angela Mazza,Barbara Fruci,Giorgia Anna Garinis,Stefania Giuliano,Roberta Malaguarnera,Antonino Belfiore,Konstantinos Kantartzis.The Role of Metformin in the Management of NAFLD[J].Experimental Diabetes Research.2011

共引文献89

同被引文献93

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部